Suchergebnisse - (Subject:"ritonavir")

PubPharm (65)

31

Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir

enthalten in: HIV clinical trials | 2009

von Rathbun, C. | Liedtke, M. | Blevins, S. | +4

32

Efficacy and safety of an NRTI-sparing dual regimen of raltegravir and ritonavir-boosted protease inhibitor in a triple antiretroviral class-experienced population

enthalten in: HIV clinical trials | 2009

von Allavena, C. | Mounoury, O. | Rodallec, A. | +3

33

Short-term effect of ritonavir-boosted atazanavir in hepatitis B and/or C co-infected, treatment-experienced HIV patients

enthalten in: HIV clinical trials | 2009

von Pérez-Elías, M. | Gatell, J. | Flores, J. | +7

34

Unboosted atazanavir plus co-formulated lamivudine/abacavir as a ritonavir-sparing simplification strategy in routine clinical practice

enthalten in: HIV clinical trials | 2009

von Santos, J. | Moltó, J. | Llibre, J. | +4

35

Occurrence of selective ritonavir nonadherence and dose-staggering in recipients of boosted HIV-1 protease inhibitor therapy

enthalten in: HIV clinical trials | 2009

von Shuter, J. | Sarlo, J. | Rode, R. | +1

36

Steady-state amprenavir, tenofovir, and emtricitabine pharmacokinetics before and after reducing ritonavir boosting of a fosamprenavir/tenofovir/emtricitabine regimen from 200 mg to 100 mg once daily (TELEX II)

enthalten in: HIV clinical trials | 2009

von Parks, D. | Jennings, H. | Taylor, C. | +2

37

Long-term efficacy and safety of fosamprenavir plus ritonavir versus lopinavir/ritonavir in combination with abacavir/lamivudine over 144 weeks

enthalten in: HIV clinical trials | 2009

von Pulido, F. | Estrada, V. | Baril, J. | +8

38

Efficacy and safety of ritonavir-boosted and unboosted atazanavir among antiretroviral-naïve patients

enthalten in: HIV clinical trials | 2008

von Horberg, M. | Klein, D. | Hurley, L. | +8

39

Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens

enthalten in: HIV clinical trials | 2008

von Pineda, J. | Pérez-Elías, M. | Peña, J. | +90

40

Cost-effectiveness of tipranavir in treatment-experienced HIV patients in the United States

enthalten in: HIV clinical trials | 2008

von Simpson, K. | Roberts, G. | Hicks, C. | +1